Why the study?
Chronic kidney disease is asymptomatic and diagnosed late, with no marker consistently and accurately predicting it before detection with traditional clinical tests.
Can a novel ultrasound technique analyzing the frequency spectrum of scattered ultrasound detect and stratify early chronic kidney disease better than traditional clinical tests?
Can a novel ultrasound technique analyzing the frequency spectrum of scattered ultrasound detect and stratify early chronic kidney disease better than traditional clinical tests?
A novel ultrasound technique analyzing the frequency spectrum of scattered waves is proposed to detect early kidney fibrosis and stratify chronic kidney disease before traditional markers become abnormal.
Answers are grounded in this paper and cite their sources.
Novel ultrasound parameter may aid early CKD detection in endemic areas; leaves open prospective validation before clinical adoption.
Chronic kidney disease (CKD) of unknown etiology is recognized as a major public health challenge and a leading cause of morbidity and mortality in the dry zone in Sri Lanka. CKD is asymptomatic and are diagnosed only in late stages. Evidence points to strong correlation between progression of CKD and kidney fibrosis. Several biochemical markers of renal fibrosis have been associated with progression of CKD. However, no marker is able to predict CKD consistently and accurately before being detected with traditional clinical tests (serum creatinine, and cystatin C, urine albumin or protein, and ultrasound scanning). In this paper, we hypothesize that fibrosis in the kidney, and therefore the severity of the disease, is reflected in the frequency spectrum of the scattered ultrasound from the kidney. We present a design of a simple ultrasound system, and a set of clinical and laboratory studies to identify spectral characteristics of the scattered ultrasound wave from the kidney that correlates with CKD. We believe that spectral parameters identified in these studies can be used to detect and stratify CKD at an earlier stage than what is possible with current markers of CKD.
No takes yet. Share an insight, caveat, or question.
Hewadikaram et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: